Lupin Atlantis Holdings SA, commonly referred to as Lupin Atlantis, is a prominent player in the pharmaceutical and biotechnology industry, headquartered in Switzerland (CH). Founded in 2005, the company has established a strong presence in Europe and Asia, focusing on innovative drug development and advanced therapeutic solutions. Specialising in generic and specialty pharmaceuticals, Lupin Atlantis is recognised for its commitment to quality and affordability. The company’s unique approach combines cutting-edge research with strategic partnerships, enabling it to deliver a diverse portfolio of products that cater to various therapeutic areas. With a solid market position, Lupin Atlantis has achieved significant milestones, including numerous regulatory approvals and collaborations that enhance its global reach. The company continues to strive for excellence, making it a noteworthy entity in the competitive landscape of the pharmaceutical sector.
We don't have data for Lupin Atlantis Holdings SA, but we can show you information about their parent organization instead.
View parent company